RPLP0 and Parkinson disease: The up-regulated DEGs were mainly enriched in functional or pathway categories such as “translation (e.g., RPS27A and RPLP0)”, “translational elongation (e.g., RPS27A and RPLP0)”, ‘ribosome (e.g., RPS27A)’, ‘ribonucleoprotein complex (e.g., RPS27A)’, ‘structural constituent of ribosome (e.g., RPS27A)’, ‘Parkinson’s disease (e.g., NDUFB3)’ and ‘oxidative phosphorylation (e.g., ATP5G3)’.